Potential PDE4B inhibitors as promising candidates against SARS‐CoV‐2 infection

Potential PDE4B inhibitors as promising candidates against SARS‐CoV‐2 infection

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an RNA virus belonging to the coronavirus family responsible for coronavirus disease 2019 (COVID-19). It primarily affects the pulmonary system, which is the target of chronic obstructive pulmonary disease (COPD), for which many new com...

Full description

Bibliographic Details
Main Authors: Giuzio Federica, Bonomo Maria Grazia, Catalano Alessia, Infantino Vittoria, Salzano Giovanni, Monné Magnus, Geronikaki Athina, Petrou Anthi, Aquaro Stefano, Sinicropi Maria Stefania, Saturnino Carmela
Format: Article
Language:English
Published: De Gruyter 2023-11-01
Series:Biomolecular Concepts
Subjects:
phosphodiesterases
sars-cov-2
molecular docking
covid-19
pde4b
piclamilast
rolipram
drug-likeness predictions
Online Access:https://doi.org/10.1515/bmc-2022-0033

Internet

https://doi.org/10.1515/bmc-2022-0033

Similar Items